remdesivir
Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients
June 5, 2020Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir
Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …
India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19
June 3, 2020Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows
June 2, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …
First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment
May 29, 2020Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir
The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
Gilead signs deal with generic drugmakers to expand global supply of remdesivir
May 13, 2020Research and Development COVID-19, coronavirus, remdesivir
Gilead Sciences has signed an exclusive licensing agreement with five generics drug companies in India and Pakistan to supply them …
Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19
May 12, 2020Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir
Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …
FDA approves emergency use of Gilead’s remdesivir for hospitalised COVID-19 patients
May 4, 2020Sales and Marketing COVID-19, FDA, Gilead, coronavirus, remdesivir
Gilead’s antiviral therapy remdesivir has shown tentatively promising efficacy in the race to find an effective treatment for COVID-19, one …
Two studies reveal “positive” data for Gilead’s remdesivir in hospitalised COVID-19 patients
April 30, 2020Research and Development COVID-19, Gilead, coronavirus, remdesivir
The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the …
Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial
April 24, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …
Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial
April 20, 2020Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir
A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …
Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days
April 17, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir
The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …
Gilead halts COVID-19 remdesivir trial due to enrolment issues, efficacy of the drug uncertain
April 16, 2020Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
A clinical trial in China investigating Gilead’s antiviral therapy remdesivir as a potential treatment for COVID-19 has been placed on …
Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients
April 14, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …
WHO launches “historic” multinational study to investigate most promising COVID-19 therapies
March 30, 2020Research and Development, Sales and Marketing COVID-19, Gilead, coronavirus, pharma, remdesivir
The World Health Organization continues to push forward in the global fight against the novel coronavirus, and has announced the …
